D-1213-2018 Class II Terminated

Recalled by Hetero Labs Limited Unit V — Jadcherla Mandal, Mahaboob Nagar

FDA drug recall D-1213-2018 was initiated by Hetero Labs Limited Unit V on Aug 20, 2018 and is designated Class II. Reason for recall: Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets. The recall status is terminated (terminated Nov 5, 2021). Affected quantity: 98,016 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 3, 2018
Initiation Date
Aug 20, 2018
Termination Date
Nov 5, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
98,016 bottles

Product description

Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-726-30.

Reason for recall

Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.

Distribution pattern

Nationwide in the USA

Code information

Lot #: MON17355, Exp 12/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1213-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1213-2018. Report a data issue: hello@regdatalab.com.